The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Poliomyelitis Vaccine-Global Market Insights and Sales Trends 2025
Synopsis
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
The global Poliomyelitis Vaccine market size is expected to reach US$ 835.1 million by 2029, growing at a CAGR of 2.3% from 2023 to 2029. The market is mainly driven by the significant applications of Poliomyelitis Vaccine in various end use industries. The expanding demands from the VAPP and VDPV, are propelling Poliomyelitis Vaccine market. Poliomyelitis Vaccine Ⅰ, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Poliomyelitis Vaccine Ⅱ segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Poliomyelitis Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Poliomyelitis Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Poliomyelitis Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Poliomyelitis Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Poliomyelitis Vaccine covered in this report include GSK, Sanofi-Pasteur, Merck, Crucell, China National Biotech Group and Eli Lilly, etc.
The global Poliomyelitis Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Sanofi-Pasteur
Merck
Crucell
China National Biotech Group
Eli Lilly
Global Poliomyelitis Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Poliomyelitis Vaccine market, Segment by Type:
Poliomyelitis Vaccine Ⅰ
Poliomyelitis Vaccine Ⅱ
Poliomyelitis Vaccine Ⅲ
Oral Poliomyelitis Vaccine
Global Poliomyelitis Vaccine market, by Application
VAPP
VDPV
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Poliomyelitis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Poliomyelitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
The global Poliomyelitis Vaccine market size is expected to reach US$ 835.1 million by 2029, growing at a CAGR of 2.3% from 2023 to 2029. The market is mainly driven by the significant applications of Poliomyelitis Vaccine in various end use industries. The expanding demands from the VAPP and VDPV, are propelling Poliomyelitis Vaccine market. Poliomyelitis Vaccine Ⅰ, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Poliomyelitis Vaccine Ⅱ segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Poliomyelitis Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Poliomyelitis Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Poliomyelitis Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Poliomyelitis Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Poliomyelitis Vaccine covered in this report include GSK, Sanofi-Pasteur, Merck, Crucell, China National Biotech Group and Eli Lilly, etc.
The global Poliomyelitis Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Sanofi-Pasteur
Merck
Crucell
China National Biotech Group
Eli Lilly
Global Poliomyelitis Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Poliomyelitis Vaccine market, Segment by Type:
Poliomyelitis Vaccine Ⅰ
Poliomyelitis Vaccine Ⅱ
Poliomyelitis Vaccine Ⅲ
Oral Poliomyelitis Vaccine
Global Poliomyelitis Vaccine market, by Application
VAPP
VDPV
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Poliomyelitis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Poliomyelitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Poliomyelitis Vaccine Market Overview
1.1 Poliomyelitis Vaccine Product Overview
1.2 Poliomyelitis Vaccine Market Segment by Type
1.2.1 Poliomyelitis Vaccine Ⅰ
1.2.2 Poliomyelitis Vaccine Ⅱ
1.2.3 Poliomyelitis Vaccine Ⅲ
1.2.4 Oral Poliomyelitis Vaccine
1.3 Global Poliomyelitis Vaccine Market Size by Type
1.3.1 Global Poliomyelitis Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Poliomyelitis Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Poliomyelitis Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Poliomyelitis Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Poliomyelitis Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Poliomyelitis Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Poliomyelitis Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Poliomyelitis Vaccine Sales Breakdown by Type (2018-2023)
2 Global Poliomyelitis Vaccine Market Competition by Company
2.1 Global Top Players by Poliomyelitis Vaccine Sales (2018-2023)
2.2 Global Top Players by Poliomyelitis Vaccine Revenue (2018-2023)
2.3 Global Top Players by Poliomyelitis Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Poliomyelitis Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Poliomyelitis Vaccine Market Competitive Situation and Trends
2.5.1 Poliomyelitis Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Poliomyelitis Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Poliomyelitis Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Poliomyelitis Vaccine Market
2.8 Key Manufacturers Poliomyelitis Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Poliomyelitis Vaccine Status and Outlook by Region
3.1 Global Poliomyelitis Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Poliomyelitis Vaccine Historic Market Size by Region
3.2.1 Global Poliomyelitis Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Poliomyelitis Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Poliomyelitis Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Poliomyelitis Vaccine Forecasted Market Size by Region
3.3.1 Global Poliomyelitis Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Poliomyelitis Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Poliomyelitis Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Poliomyelitis Vaccine by Application
4.1 Poliomyelitis Vaccine Market Segment by Application
4.1.1 VAPP
4.1.2 VDPV
4.2 Global Poliomyelitis Vaccine Market Size by Application
4.2.1 Global Poliomyelitis Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Poliomyelitis Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Poliomyelitis Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Poliomyelitis Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Poliomyelitis Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Poliomyelitis Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Poliomyelitis Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Poliomyelitis Vaccine Sales Breakdown by Application (2018-2023)
5 North America Poliomyelitis Vaccine by Country
5.1 North America Poliomyelitis Vaccine Historic Market Size by Country
5.1.1 North America Poliomyelitis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Poliomyelitis Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Poliomyelitis Vaccine Sales in Value by Country (2018-2023)
5.2 North America Poliomyelitis Vaccine Forecasted Market Size by Country
5.2.1 North America Poliomyelitis Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Poliomyelitis Vaccine Sales in Value by Country (2024-2029)
6 Europe Poliomyelitis Vaccine by Country
6.1 Europe Poliomyelitis Vaccine Historic Market Size by Country
6.1.1 Europe Poliomyelitis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Poliomyelitis Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Poliomyelitis Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Poliomyelitis Vaccine Forecasted Market Size by Country
6.2.1 Europe Poliomyelitis Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Poliomyelitis Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Poliomyelitis Vaccine by Region
7.1 Asia-Pacific Poliomyelitis Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Poliomyelitis Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Poliomyelitis Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Poliomyelitis Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Poliomyelitis Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Poliomyelitis Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Poliomyelitis Vaccine Sales in Value by Region (2024-2029)
8 Latin America Poliomyelitis Vaccine by Country
8.1 Latin America Poliomyelitis Vaccine Historic Market Size by Country
8.1.1 Latin America Poliomyelitis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Poliomyelitis Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Poliomyelitis Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Poliomyelitis Vaccine Forecasted Market Size by Country
8.2.1 Latin America Poliomyelitis Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Poliomyelitis Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Poliomyelitis Vaccine by Country
9.1 Middle East and Africa Poliomyelitis Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Poliomyelitis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Poliomyelitis Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Poliomyelitis Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Poliomyelitis Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Poliomyelitis Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Poliomyelitis Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GSK Poliomyelitis Vaccine Products Offered
10.1.5 GSK Recent Development
10.2 Sanofi-Pasteur
10.2.1 Sanofi-Pasteur Company Information
10.2.2 Sanofi-Pasteur Introduction and Business Overview
10.2.3 Sanofi-Pasteur Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi-Pasteur Poliomyelitis Vaccine Products Offered
10.2.5 Sanofi-Pasteur Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Poliomyelitis Vaccine Products Offered
10.3.5 Merck Recent Development
10.4 Crucell
10.4.1 Crucell Company Information
10.4.2 Crucell Introduction and Business Overview
10.4.3 Crucell Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Crucell Poliomyelitis Vaccine Products Offered
10.4.5 Crucell Recent Development
10.5 China National Biotech Group
10.5.1 China National Biotech Group Company Information
10.5.2 China National Biotech Group Introduction and Business Overview
10.5.3 China National Biotech Group Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 China National Biotech Group Poliomyelitis Vaccine Products Offered
10.5.5 China National Biotech Group Recent Development
10.6 Eli Lilly
10.6.1 Eli Lilly Company Information
10.6.2 Eli Lilly Introduction and Business Overview
10.6.3 Eli Lilly Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Eli Lilly Poliomyelitis Vaccine Products Offered
10.6.5 Eli Lilly Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Poliomyelitis Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Poliomyelitis Vaccine Industrial Chain Analysis
11.4 Poliomyelitis Vaccine Market Dynamics
11.4.1 Poliomyelitis Vaccine Industry Trends
11.4.2 Poliomyelitis Vaccine Market Drivers
11.4.3 Poliomyelitis Vaccine Market Challenges
11.4.4 Poliomyelitis Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Poliomyelitis Vaccine Distributors
12.3 Poliomyelitis Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
